Cargando…
Ex vivo Measurement of the Radioactivity of PET/CT-Guided Biopsy Specimen: Is it Helpful to Confirm the Sampling from a Viable Region of the Tumor and the Nature of the Lesion?
OBJECTIVE: Ex vivo radioactivity measurement of positron emission tomography/computed tomography (PET/CT)-guided biopsy tissue specimen to check the viable tumor sampling and predict the nature of the biopsied lesion. MATERIALS AND METHODS: We prospectively evaluated the retrieved tissue specimens d...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380811/ https://www.ncbi.nlm.nih.gov/pubmed/35982818 http://dx.doi.org/10.4103/ijnm.ijnm_172_21 |
_version_ | 1784768948594540544 |
---|---|
author | Kaur, Navjot Kumar, Rajender Rana, Nivedita Krishnaraju, Venkata Subramanian Mittal, Bhagwant Rai |
author_facet | Kaur, Navjot Kumar, Rajender Rana, Nivedita Krishnaraju, Venkata Subramanian Mittal, Bhagwant Rai |
author_sort | Kaur, Navjot |
collection | PubMed |
description | OBJECTIVE: Ex vivo radioactivity measurement of positron emission tomography/computed tomography (PET/CT)-guided biopsy tissue specimen to check the viable tumor sampling and predict the nature of the biopsied lesion. MATERIALS AND METHODS: We prospectively evaluated the retrieved tissue specimens during PET/CT-guided biopsies for the presence of radioactivity. The qualitative radioactivity was measured by acquiring PET/CT images of the specimen. For quantitative analysis, a multichannel-analyzer (MCA) was used, and a counting-factor (CF) in counts/mCi.mm(3) was calculated based on background-corrected net-counts, tissue-volume (mm(3)), and exponential tracer-activity during biopsy (mCi). The CF-values were compared with the 2-(fluorine-18) fluoro-2-deoxy-D-glucose-avidity in the target lesion and correlated with the histopathology. RESULTS: A total of 49 patients (30 males) aged 51.8 ± 17.8 years were recruited for the biopsy, and radioactivity was measured. All the specimens revealed the presence of radioactivity on PET/CT images of the specimens and MCA counting. The mean CF-values were 17.2 ± 15.6 counts/mCi.mm(3). One sample had meager counts with a CF-value of 0.162 and was subjected to re-biopsy after repositioning the coaxial needle to the hypermetabolic site. Pathological diagnosis was established in all the patients (malignancy-29, benign-20). The CF-values were significantly higher in malignant lesions than benign (21.45 ± 18.05 vs. 10.76 ± 8.96 counts/mCi.mm(3), P = 0.025). CF-values and maximum standardized uptake value had a significant correlation (Pearson's r = 0.457, P = 0.001). CONCLUSION: The ex vivo measurement of the radioactivity of retrieved tissue specimens during PET/CT-guided biopsy helps to confirm the sampling from viable region and a highly practical approach to avoid erroneous sampling of a lesion with a large necrotic area. It is also helpful in predicting the nature of the biopsied lesion before the histopathological analysis. |
format | Online Article Text |
id | pubmed-9380811 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-93808112022-08-17 Ex vivo Measurement of the Radioactivity of PET/CT-Guided Biopsy Specimen: Is it Helpful to Confirm the Sampling from a Viable Region of the Tumor and the Nature of the Lesion? Kaur, Navjot Kumar, Rajender Rana, Nivedita Krishnaraju, Venkata Subramanian Mittal, Bhagwant Rai Indian J Nucl Med Original Article OBJECTIVE: Ex vivo radioactivity measurement of positron emission tomography/computed tomography (PET/CT)-guided biopsy tissue specimen to check the viable tumor sampling and predict the nature of the biopsied lesion. MATERIALS AND METHODS: We prospectively evaluated the retrieved tissue specimens during PET/CT-guided biopsies for the presence of radioactivity. The qualitative radioactivity was measured by acquiring PET/CT images of the specimen. For quantitative analysis, a multichannel-analyzer (MCA) was used, and a counting-factor (CF) in counts/mCi.mm(3) was calculated based on background-corrected net-counts, tissue-volume (mm(3)), and exponential tracer-activity during biopsy (mCi). The CF-values were compared with the 2-(fluorine-18) fluoro-2-deoxy-D-glucose-avidity in the target lesion and correlated with the histopathology. RESULTS: A total of 49 patients (30 males) aged 51.8 ± 17.8 years were recruited for the biopsy, and radioactivity was measured. All the specimens revealed the presence of radioactivity on PET/CT images of the specimens and MCA counting. The mean CF-values were 17.2 ± 15.6 counts/mCi.mm(3). One sample had meager counts with a CF-value of 0.162 and was subjected to re-biopsy after repositioning the coaxial needle to the hypermetabolic site. Pathological diagnosis was established in all the patients (malignancy-29, benign-20). The CF-values were significantly higher in malignant lesions than benign (21.45 ± 18.05 vs. 10.76 ± 8.96 counts/mCi.mm(3), P = 0.025). CF-values and maximum standardized uptake value had a significant correlation (Pearson's r = 0.457, P = 0.001). CONCLUSION: The ex vivo measurement of the radioactivity of retrieved tissue specimens during PET/CT-guided biopsy helps to confirm the sampling from viable region and a highly practical approach to avoid erroneous sampling of a lesion with a large necrotic area. It is also helpful in predicting the nature of the biopsied lesion before the histopathological analysis. Wolters Kluwer - Medknow 2022 2022-07-08 /pmc/articles/PMC9380811/ /pubmed/35982818 http://dx.doi.org/10.4103/ijnm.ijnm_172_21 Text en Copyright: © 2022 Indian Journal of Nuclear Medicine https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Kaur, Navjot Kumar, Rajender Rana, Nivedita Krishnaraju, Venkata Subramanian Mittal, Bhagwant Rai Ex vivo Measurement of the Radioactivity of PET/CT-Guided Biopsy Specimen: Is it Helpful to Confirm the Sampling from a Viable Region of the Tumor and the Nature of the Lesion? |
title | Ex vivo Measurement of the Radioactivity of PET/CT-Guided Biopsy Specimen: Is it Helpful to Confirm the Sampling from a Viable Region of the Tumor and the Nature of the Lesion? |
title_full | Ex vivo Measurement of the Radioactivity of PET/CT-Guided Biopsy Specimen: Is it Helpful to Confirm the Sampling from a Viable Region of the Tumor and the Nature of the Lesion? |
title_fullStr | Ex vivo Measurement of the Radioactivity of PET/CT-Guided Biopsy Specimen: Is it Helpful to Confirm the Sampling from a Viable Region of the Tumor and the Nature of the Lesion? |
title_full_unstemmed | Ex vivo Measurement of the Radioactivity of PET/CT-Guided Biopsy Specimen: Is it Helpful to Confirm the Sampling from a Viable Region of the Tumor and the Nature of the Lesion? |
title_short | Ex vivo Measurement of the Radioactivity of PET/CT-Guided Biopsy Specimen: Is it Helpful to Confirm the Sampling from a Viable Region of the Tumor and the Nature of the Lesion? |
title_sort | ex vivo measurement of the radioactivity of pet/ct-guided biopsy specimen: is it helpful to confirm the sampling from a viable region of the tumor and the nature of the lesion? |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380811/ https://www.ncbi.nlm.nih.gov/pubmed/35982818 http://dx.doi.org/10.4103/ijnm.ijnm_172_21 |
work_keys_str_mv | AT kaurnavjot exvivomeasurementoftheradioactivityofpetctguidedbiopsyspecimenisithelpfultoconfirmthesamplingfromaviableregionofthetumorandthenatureofthelesion AT kumarrajender exvivomeasurementoftheradioactivityofpetctguidedbiopsyspecimenisithelpfultoconfirmthesamplingfromaviableregionofthetumorandthenatureofthelesion AT rananivedita exvivomeasurementoftheradioactivityofpetctguidedbiopsyspecimenisithelpfultoconfirmthesamplingfromaviableregionofthetumorandthenatureofthelesion AT krishnarajuvenkatasubramanian exvivomeasurementoftheradioactivityofpetctguidedbiopsyspecimenisithelpfultoconfirmthesamplingfromaviableregionofthetumorandthenatureofthelesion AT mittalbhagwantrai exvivomeasurementoftheradioactivityofpetctguidedbiopsyspecimenisithelpfultoconfirmthesamplingfromaviableregionofthetumorandthenatureofthelesion |